Carlsmed (CARL) Shares Outstanding (Weighted Average) (2024 - 2026)

Carlsmed has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $26.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 524.16% year-over-year to $26.8 million; the trailing twelve-month figure through Mar 2026 stood at $26.8 million (up 524.16% YoY), and the FY2025 full-year result was $14.2 million, up 249.74% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $26.8 million, up from $14.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $26.8 million in Q1 2026, with the low at $4.0 million in Q2 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $9.0 million across 3 years, with a median of $4.4 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) advanced 14.04% — and 2026, when it soared 524.16%.
• Carlsmed's Shares Outstanding (Weighted Average) stood at $4.1 million in 2024, then surged by 249.74% to $14.2 million in 2025, then soared by 88.69% to $26.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $26.8 million (Q1 2026), $14.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.